The clinical development of the glass-ionomer cement. III. The erosion lesion.
A clinical trial of the glass-ionomer cement, ASPA IV, as a restorative material for erosion lesions is reported. The failure rate, in a three-year trial, was nine per cent; most failures occurring within the first few months after placement.
D000180:Acrylic Resins; D001840:Dental Bonding; D003737:Dental Cavity Preparation; D003793:Dental Restoration, Permanent / Q000379:methods; D005898:Glass; D006801:Humans; D011076:Polycarboxylate Cement; D014077:Tooth Erosion / Q000628:therapy*
D000180:Acrylic Resins; D011076:Polycarboxylate Cement